We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$683M
AUM Growth
+$58.2M
(+9.3%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
226
New
14
Increased
153
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.97M |
| 2 |
Arista Networks
ANET
|
+$2.33M |
| 3 |
BCPC
Balchem Corp
BCPC
|
+$2.09M |
| 4 |
Quest Diagnostics
DGX
|
+$1.56M |
| 5 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.54M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.95M |
| 3 |
Comcast
CMCSA
|
+$1.76M |
| 4 |
CDW
CDW
|
+$1.48M |
| 5 |
Medtronic
MDT
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Healthcare | 8.13% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Medtronic
MDT
$109B
| $1.1M | 0.16% |
12,668
-15,912
| -56% | -$1.35M |
|
127
Duke Energy
DUK
$97.8B
| $1.1M | 0.16% |
9,341
+275
| +3% | +$32.5K |
|
128
Keysight
KEYS
$54.5B
| $1.09M | 0.16% |
6,635
+39
| +0.6% | +$5.94K |
|
129
Paychex
PAYX
$41.6B
| $1.08M | 0.16% |
7,456
-1,275
| -15% | -$192K |
|
130
Lamar Advertising Co
LAMR
$16.2B
| $1.02M | 0.15% |
8,435
+4,027
| +91% | +$467K |
|
131
Icon
ICLR
$12.6B
| $1.01M | 0.15% |
6,938
+1,340
| +24% | +$190K |
|
132
Lockheed Martin
LMT
$134B
| $1.01M | 0.15% |
2,171
+70
| +3% | +$32.8K |
|
133
AT&T
T
$159B
| $990K | 0.15% |
34,216
+236
| +0.7% | +$6.5K |
|
134
Target
TGT
$65.6B
| $982K | 0.14% |
9,950
-155
| -2% | -$14.9K |
|
135
Idacorp
IDA
$8.27B
| $952K | 0.14% |
8,248
+343
| +4% | +$39.7K |
|
136
Nasdaq
NDAQ
$52.7B
| $937K | 0.14% |
10,474
+308
| +3% | +$24.6K |
|
137
Ollie's Bargain Outlet
OLLI
$4.44B
| $914K | 0.13% |
6,938
+408
| +6% | +$46.7K |
|
|
138
Comcast
CMCSA
$85B
| $886K | 0.13% |
24,835
-50,813
| -67% | -$1.76M |
|
139
Burlington
BURL
$23.2B
| $874K | 0.13% |
3,756
+210
| +6% | +$49.9K |
|
|
SF
140
Stifel
SF
$12.6B
| $863K | 0.13% |
12,477
+732
| +6% | +$45K |
|
141
Casey's General Stores
CASY
$32.2B
| $836K | 0.12% |
1,638
+97
| +6% | +$44.7K |
|
142
Baxter International
BAX
$13.5B
| $802K | 0.12% |
26,491
+3,331
| +14% | +$101K |
|
143
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $793K | 0.12% |
1,283
| – | – |
|
144
Starbucks
SBUX
$120B
| $791K | 0.12% |
8,635
+305
| +4% | +$26.4K |
|
145
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $784K | 0.11% |
5,879
+1,485
| +34% | +$188K |
|
146
Vanguard Morningstar Growth ETF
VUG
$220B
| $780K | 0.11% |
10,674
+1,338
| +14% | +$88.1K |
|
147
Advanced Micro Devices
AMD
$776B
| $723K | 0.11% |
5,095
+120
| +2% | +$13.1K |
|
148
Franklin Electric
FELE
$4.63B
| $698K | 0.1% |
7,783
+10
| +0.1% | +$877 |
|
149
CACI
CACI
$11B
| $683K | 0.1% |
1,433
+84
| +6% | +$37.2K |
|
|
SCHW
150
Charles Schwab
SCHW
$183B
| $676K | 0.1% |
7,413
-2,987
| -29% | -$250K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, First National Advisers held 226 positions worth $683M, up 9.3% from $625M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
First National Advisers's Q2 2025 filing shows 14 new, 153 increased, 40 reduced and 5 closed positions. Its largest new stake was Arista Networks: 26,985 shares worth $2.76M. The largest sale was Jazz Pharmaceuticals, an estimated $2.54M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- First National Advisers's largest Q2 2025 buy was Arista Networks: 26,985 shares worth $2.76M.
- First National Advisers added most to AbbVie in Q2 2025, an estimated $3.97M increase.
- First National Advisers's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.95M.
- First National Advisers fully exited Jazz Pharmaceuticals in Q2 2025, selling an estimated $2.54M.
- First National Advisers's ten largest holdings make up 36% of its $683M portfolio in Q2 2025.
- First National Advisers opened 14 new positions and closed 5 in Q2 2025.
- First National Advisers's portfolio value rose 9.3% quarter-over-quarter to $683M.
Based on First National Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.